Titlebook: Advances in Targeted Cancer Therapy; Paul L. Herrling,Alex Matter (Director),Richard M. Book 2005 Birkhäuser Basel 2005 angiogenesis.antib

显示全部楼层 · 发表于 2025-3-23 19:03:47

Angiogenesis inhibitors: What is the clinical future?,s or classic chemotherapy, there is no longer doubt that anti-angiogenic agents have become part of anticancer therapy in general. In the coming years, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate

显示全部楼层 · 发表于 2025-3-23 23:24:03

显示全部楼层 · 发表于 2025-3-24 04:15:42

https://doi.org/10.1007/3-7643-7414-4angiogenesis; antibody; apoptosis; cancer; cancer prevention; cancer therapy; cancer treatment; cell; metast

显示全部楼层 · 发表于 2025-3-24 09:25:20

显示全部楼层 · 发表于 2025-3-24 11:23:59

Paul L. Herrling,Alex Matter (Director),Richard M.Excellent overview of new approaches for the treatment of cancer.Covers a large range of molecular targets.Discusses the potential for clinical application

显示全部楼层 · 发表于 2025-3-24 14:52:01

Progress in Drug Researchhttp://image.papertrans.cn/a/image/149983.jpg

显示全部楼层 · 发表于 2025-3-24 19:52:22

显示全部楼层 · 发表于 2025-3-25 00:49:41

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-21 20:03
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved